Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:09:45 EDT Wed 09 Jul 2025
Enter Symbol
or Name
USA
CA



Q:PGEN - PRECIGEN INC - http://www.precigen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PGEN - Q0.11.54·1.751.21.70+0.116.91,742.42,7433,0081.60  1.71  1.602.17  0.6513Jul 08May 1415 min RT 2¢

Recent Trades - Last 10 of 3008
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-14 16:05U:PGENNews ReleasePrecigen Reports First Quarter 2025 Financial Results and Business Updates
2025-04-16 08:05U:PGENNews ReleasePrecigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
2025-03-19 16:05U:PGENNews ReleasePrecigen Reports Full Year 2024 Financial Results and Business Updates
2025-03-13 08:05U:PGENNews ReleasePrecigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
2025-02-25 08:05U:PGENNews ReleaseFDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025
2025-01-13 07:00U:PGENNews ReleasePrecigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference
2025-01-09 08:30U:PGENNews ReleasePrecigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-30 07:00U:PGENNews ReleasePrecigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis
2024-12-27 09:00U:PGENNews ReleasePrecigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
2024-11-14 16:30U:PGENNews ReleasePrecigen Reports Third Quarter 2024 Financial Results and Business Updates
2024-11-12 16:05U:PGENNews ReleasePrecigen to Participate in the Stifel 2024 Healthcare Conference
2024-09-16 16:30U:PGENNews ReleasePrecigen to Participate in the 2024 Cantor Global Healthcare Conference
2024-08-14 16:05U:PGENNews ReleasePrecigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
2024-08-09 08:00U:PGENNews ReleasePrecigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th
2024-08-07 21:30U:PGENNews ReleasePrecigen Announces Pricing of $30.0 Million Public Offering of Common Stock
2024-08-06 16:04U:PGENNews ReleasePrecigen Announces Proposed $30 Million Public Offering of Common Stock
2024-08-06 16:01U:PGENNews ReleasePrecigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch
2024-07-23 08:01U:PGENNews ReleasePrecigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch